SC
STRO icon

Steven Cohen’s Sutro Biopharma STRO Stock Holding History

Steven Cohen’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.9M Sell
237,827
-454,284
-66% -$14.2M 0.01% 1432
2026
Q1 		$17.2M Buy
692,111
+513,023
+286% +$9.27M 0.02% 887
2025
Q4 		$2.07M Buy
+179,088
New +$1.7M ﹤0.01% 2449
2025
Q1 		– Sell
-219,754
Closed -$4.04M – 2514
2024
Q4 		$4.04M Sell
219,754
-79,991
-27% -$2.44M 0.01% 1020
2024
Q3 		$10.4M Sell
299,745
-145,018
-33% -$5.68M 0.03% 635
2024
Q2 		$13M Buy
444,763
+418,693
+1,606% +$16.6M 0.03% 520
2024
Q1 		$1.47M Sell
26,070
-2,500
-9% -$110K ﹤0.01% 1364
2023
Q4 		$1.23M Sell
28,570
-24,745
-46% -$785K ﹤0.01% 1345
2023
Q3 		$1.85M Buy
53,315
+32,415
+155% +$1.41M 0.01% 1151
2023
Q2 		$972K Buy
+20,900
New +$1.04M ﹤0.01% 1147
2023
Q1 		– Sell
-79,060
Closed -$6.39M – 2529
2022
Q4 		$6.39M Buy
79,060
+7,960
+11% +$553K 0.02% 685
2022
Q3 		$3.95M Buy
+71,100
New +$4.21M 0.02% 786
2021
Q4 		– Sell
-37,500
Closed -$7.08M – 1291
2021
Q3 		$7.08M Sell
37,500
-76,160
-67% -$14.5M 0.03% 578
2021
Q2 		$21.1M Buy
113,660
+17,840
+19% +$3.49M 0.09% 274
2021
Q1 		$21.8M Sell
95,820
-45,111
-32% -$10.7M 0.1% 244
2020
Q4 		$30.6M Buy
140,931
+39,881
+39% +$6.6M 0.15% 189
2020
Q3 		$10.2M Buy
101,050
+41,050
+68% +$3.88M 0.05% 402
2020
Q2 		$4.66M Buy
+60,000
New +$5.76M 0.03% 495
2019
Q3 		– Sell
-32,238
Closed -$3.67M – 1450
2019
Q2 		$3.67M Buy
+32,238
New +$3.55M 0.02% 570

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Steven Cohen's STRO Position: Q2 2026 in Review

Steven Cohen reduced its Sutro Biopharma (STRO) stake by 66% in Q2 2026, selling an estimated $14.2M and leaving 237,827 shares worth $7.9M. The position accounts for 0.01% of the portfolio, ranked #1432.

Steven Cohen first reported a position in STRO in Q2 2019 and has held it in 19 quarters since. The position peaked at $30.6M in Q4 2020. 99 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Steven Cohen held 237,827 shares of Sutro Biopharma worth $7.9M as of Q2 2026.
  • Steven Cohen sold 454,284 Sutro Biopharma shares in Q2 2026, an estimated $14.2M.
  • Sutro Biopharma made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1432 holding.
  • Steven Cohen first reported a position in Sutro Biopharma in Q2 2019 and has held it in 19 quarters since.
  • Steven Cohen's Sutro Biopharma position peaked at $30.6M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.